何宗琳Lillian He

资深顾问律师

上海 + 86.21.2201.8034

何宗琳律师的执业领域主要是帮助跨国公司经办其在中国和美国的争议解决和公司内部调查事项,包括美国诉讼、美国证券管理委员会的执法、美国贸易管制、美国《反海外腐败法》调查及中国反贿赂法律合规等事项。

何宗琳律师在近期协助多家美国公众公司回应政府部门对其在中国违反《反海外腐败法》规定情况的调查,并协助一些在中国和亚洲地区有重大经营业务的跨国公司进行全球合规审查工作。何宗琳律师曾代理中国公司进行在美国的诉讼。何宗琳律师还曾就美国财政部下属外国资产管制办公室负责的经济制裁计划向客户提供相关法律咨询。

何宗琳律师还对跨国公司的数据安全、环境保护、外国直接投资和一般公司事务拥有丰富的执业经验,曾经代理中国各行各业的客户经办所委托的事项,这些行业如化妆品包装、汽车和汽车零部件制造、医药分销和特许及许可等。

经验

  • Helios Technologies completes acquisition of assets of JoyonwayJones Day advised Helios Technologies, Inc. in the acquisition of assets related to the electronic control systems and parts business of Shenzhen Joyonway Electronics & Technology Co., Ltd and its related entities (collectively “Joyonway”).
  • Chinese financial institution secures early dismissal of breach of contract case filed in New York Supreme CourtJones Day helped a Chinese financial institution secure an early dismissal of a breach of contract case that plaintiffs filed in New York Supreme Court.
  • Telecommunications joint venture defends against enforcement measures that were brought following cross-border arbitrationJones Day represented a telecommunications joint venture in defending against efforts to enforce a partial arbitral award against it in Chinese courts.
  • U.S. fashion retailer reviews internal reports of alleged kickbacks and alleged misconductJones Day reviewed internal reports of alleged kickbacks and alleged misconduct raised by a client’s supplier, and helped the client carry out remedial measures following review.
  • Life sciences company resolves FCPA issues with DOJ and SECJones Day represented a publicly traded life sciences company in an internal investigation and resulting self-disclosure to the U.S. Department of Justice ("DOJ") and U.S. Securities and Exchange Commission ("SEC") involving alleged Foreign Corrupt Practices Act ("FCPA") violations arising out of the company's China operations.
  • Chinese financial institution responds to subpoena for records in major U.S. investigationJones Day represented a Chinese financial institution in a matter relating to a significant U.S. government investigation.
  • Global industrial manufacturing company revises compliance programJones Day assisted a global industrial manufacturing company in revising its third-party compliance policies and controls.
  • Global services company investigates allegations of corruption in its China operationsJones Day assisted a global services company investigate allegations of corrupt payments in its China sales operations.
  • Shenglong Technologies reaches settlement against former broker in U.S. district courtJones Day represented Ningbo Superim Shenglong Technologies Co., Ltd. and its parent company, Yinyi Group Co., Ltd. in U.S. district court against Shenglong's former broker in a factory acquisition.
  • HNA settles trademark infringement action relating to musical workJones Day represented Hainan Airlines Holding Co., Ltd. ("HNA") in a trademark infringement action relating to the use of a musical work.
  • Public company discloses FCPA issues to DOJ and SECJones Day coordinated the internal investigation and resulting self-disclosure to the U.S. Department of Justice ("DOJ") and the U.S. Securities and Exchange Commission ("SEC") for a public company involved in industrial and manufacturing work regarding Foreign Corrupt Practices Act ("FCPA") issues arising out of the company’s China office.
  • Automotive parts company conducts internal investigationOn behalf of an automotive parts company, Jones Day conducted an internal investigation into allegations of misconduct, self-dealing, and bribery related to the client’s subsidiary and distributor.
  • Pharmaceutical company successfully defends charge of commercial briberyA pharmaceutical company represented by Jones Day (in conjunction with local counsel) successfully challenged a charge of commercial bribery by a local branch of the Shanghai Administration of Industry and Commerce (AIC).
  • Sherwin-Williams acquires Valspar for $11.3 billionJones Day advised The Sherwin-Williams Company in its $11.3 billion acquisition of The Valspar Corporation.
  • Public life sciences company conducts anti-corruption due diligence on multiple acquisition targets in ChinaJones Day counseled a public U.S. life sciences company with respect to anti-corruption due diligence on more than a dozen acquisition targets operating in China.
  • Publicly traded company conducts anti-corruption investigation of physician sponsorship payments in Asia PacificJones Day assisted a publicly traded company with an investigation of whistleblower allegations that physician sponsorship payments in Asia Pacific violated U.S. and local anti-corruption laws.